DDInter1610 DDInter1180
Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Rivastigmine {u} (Compound) resembles {v} (Compound) Pyridostigmine
Rivastigmine {u} (Compound) resembles {v} (Compound) Tapentadol
Rivastigmine {u} (Compound) treats {v} (Disease) Alzheimer's disease
Rivastigmine {u} (Compound) binds {v} (Gene) ACHE
Rivastigmine {u} (Compound) upregulates {v} (Gene) GHR
Rivastigmine {u} (Compound) palliates {v} (Disease) Parkinson's disease
Rivastigmine {u} (Compound) downregulates {v} (Gene) CCNH
Rivastigmine {u} (Compound) causes {v} (Side Effect) Cutaneous hypersensitivity
Rivastigmine (Compound) resembles Pyridostigmine (Compound)
Rivastigmine (Compound) resembles Tapentadol (Compound)
Rivastigmine (Compound) treats Alzheimer's disease (Disease)
Rivastigmine (Compound) binds ACHE (Gene)
Rivastigmine (Compound) upregulates GHR (Gene)
Rivastigmine (Compound) palliates Parkinson's disease (Disease)
Rivastigmine (Compound) downregulates CCNH (Gene)
Rivastigmine (Compound) causes Cutaneous hypersensitivity (Side Effect)